Adrian John Lowe
Adrian John Lowe holds an M.P.H. degree in epidemiology and biostatistics, and he completed his Ph.D. degree in 2007 at the University of Melbourne, Melbourne, VIC, Australia. His thesis was awarded both a Deans Award and a School of Population Health’s Head’s Award for Excellence. He currently holds positions at the University of Melbourne and Murdoch Childrens Research Institute, Melbourne, Australia. Moreover, he spent the first half of 2011 at the University of Umeå, Sweden, as a Guest Researcher. His research focuses on identifying modifiable, early-life, risk factors that can lead to interventions to help reduce the epidemic of allergic diseases that we face within developed countries. He has recently published in the BMJ on the association between early-life exposure to paracetamol and the development of childhood asthma and in the Journal of Allergy and Clinical Immunology on the association between maternal obesity and childhood asthma. In addition, his research is based on a number of important projects on the development of allergic disease in children. He is an Investigator and a Research Fellow on the Melbourne Atopy Cohort Study, a longitudinal study of 620 high-risk children and their families. He is also an Investigator on (i) the HealthNuts study, a population prevalence study of food allergy in Melbourne children, which is commenced in 2007, and (ii) the Tasmanian Longitudinal Health Study, the world’s largest and longest running respiratory health research study. He is also a Researcher of the Umeå SIMSAM node, which aims to use registry-based information for research purposes. Since commencing his postdoc period in 2008, he has developed a clinical trial that aims to reduce the incidence of eczema in high-risk infants by use of a specialized skin treatment. He is the principal investigator for this trial, and we have recently completed a pilot study. He will soon commence a trial involving 100 children.
Biography Updated on 30 April 2012